T2 BIOSYSTEMS INC

COM · CUSIP 89853L104

2 institutional holders -61 vs Q3 2022

119,501119.5k shares reported held*

$109.0kreported value*

0 new 0 added 0 reduced 61 sold out net sold ≈ $7.6m (-24.6m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.91.

Trends to Q4 2022

Institutional holders

Managers reporting a position, each quarter

Numbers

Quarter	Holders
Q3 2022	63
Q4 2022	2

Calls vs puts

Options held, notional value, last 4 quarters. P/C = puts ÷ calls

CallsPuts

Numbers

Quarter	Calls	Puts	P/C
Q3 2022	$21.0k	$9.0k	0.43
Q4 2022	$0	$0	—

Biggest buyers

None

Biggest sellers

VANGUARD GROUP INC	Sold out	-9,088,832-9.1m
Altium Capital Management LLC	Sold out	-2,840,000-2.8m
BlackRock Inc.	Sold out	-2,564,299-2.6m
GSA CAPITAL PARTNERS LLP	Sold out	-1,954,463-2.0m
GEODE CAPITAL MANAGEMENT, LLC	Sold out	-1,538,130-1.5m
SUSQUEHANNA INTERNATIONAL GROUP, LLP	Sold out	-766,434-766.4k
GAGNON SECURITIES LLC	Sold out	-766,302-766.3k
STATE STREET CORP	Sold out	-646,500-646.5k
Bank of New York Mellon Corp	Sold out	-538,540-538.5k
MORGAN STANLEY	Sold out	-423,813-423.8k

Holders, Q4 2022

#	Manager	Location	Shares	Value	% of their portfolio	Change	Shares change
1	McAdam, LLC 0.01% of their portfolio	Philadelphia, PA	113,201113.2k $58.0k	$58.0k	0.01%	Unchanged
2	IFP Advisors, Inc 0.00% of their portfolio	TAMPA, FL	6,3006.3k $51.0k	$51.0k	0.00%	Unchanged